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Objectives: Assisted reproductive technology is commonly used for women with infertility. We report a
case of acute intermittent porphyria associated with in vitro fertilization treatment.
Case Report: A 35-year-old womanwith tubal factor infertility presented to our clinic with persistent low
abdominal pain and hyponatremia after transvaginal oocyte retrieval. During admission, she experienced
a generalized toniceclonic seizure attacked following by dark brown color urine. Urinary tests showed
elevated porphobilinogen, 5-aminolevulinic acid, uroporphyrin, and coproporphyrin, conﬁrming the
diagnosis of acute intermittent porphyria. The patient's condition continued to improve after hemin
treatment and rehabilitation.
Conclusion: Newly onset acute intermittent porphyria during the course of controlled ovarian hyper-
stimulation for in vitro fertilization is a rare but possible complication. Acute intermittent porphyria
should be taken into consideration for persisted unexplained abdominal pain and seriously alerted if
accompanied with neurological symptoms. Special tests for acute intermittent porphyria should be taken
into consideration for the differential diagnosis of lower abdominal pain after oocyte retrieval.
Copyright © 2016, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).Introduction
Acute intermittent porphyria (AIP) is an autosomal dominant
disorder with low penetrance resulting from a partial deﬁciency of
the heme biosynthetic enzyme porphobilinogen deaminase [1].
Alterations in the enzymes of heme biosynthesis cause a variety of
neurovisceral symptoms. The diagnosis of AIP should be considered
in many patients with otherwise unexplained abdominal pain,
severe constipation, systemic arterial hypertension, or other char-
acteristic symptoms. It is a rare disease which affects reproductive
age women more commonly than men. Development of symptoms
is affected by a variety of exacerbating factors including sex
hormones.
Oocyte retrieval in assisted reproductive technology is nowa-
days achieved almost exclusively by the transvaginal ultrasound-
guided follicle aspiration method. Hormonal level ﬂuctuations
before and after oocytes retrieval could potentially induces and Gynecology, National
, National Cheng Kung Uni-
iwan.
. Wu).
bstetrics & Gynecology. Published bexacerbations of AIP. We present a case of AIP exacerbations
manifested as a rare complication which may be associated with
hormonal ﬂuctuation during in vitro fertilization (IVF) treatment.Case Report
A 35-year-old nulliparous woman with a history of ectopic
pregnancy came to our infertility department in hopes of preg-
nancy. Bilateral tubal occlusion was suspected under hysterosal-
pingography and IVF treatment was advised. The ﬂare up protocol
with gonadotropin-releasing hormone agonist (Leuprolide Acetate;
FAMR L’AiGLE, France) 1.0 mg per day was administered subcuta-
neously until the day of human chorionic gonadotropin (HCG).
Controlled ovarian hyperstimulation was achieved by a total of
1200 IU recombinant follicle stimulating hormone (Puregon;
Organon, Oss, the Netherlands) and 75 IU recombinant luteinizing
hormone (Luveris; Merck-Serono, Darmstadt, Germany). HCG was
given to trigger ovulation. The patient's estrogen level was 3650 pg/
mL and progesterone level was 1.86 ng/mL on the day of HCG
administration. Transvaginal oocyte retrieval (TVOR) was done
smoothly 36 hours after the administration of HCG, with a total ofy Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
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on the day of HCG, all fertilized embryos were cryopreserved.
The woman presented to the emergency department (ED) on
the next day after the surgery with acute onset lower abdominal
pain. Physical examinations showed lower abdominal tenderness
and rebound tenderness. Small amount of ascites was noted under
ultrasonography and post-TVOR peritonitis was suspected. Her
symptoms improved gradually after the administration of intra-
venous ﬂuid, oral antibiotics, and analgesics. She was then dis-
charged from the ED after 57 hours of stay.
The patient presented to the ED again 4 days after TVOR. This
time, she complained of right upper quadrant and lower abdominal
pain. Nausea and vomiting were also found. Laboratory work-up
was unremarkable except for hyponatremia (Na 127 mmol/L). Im-
aging studies with abdominal ultrasonography and computed to-
mography (CT) revealed enlarged bilateral adnexae with small
amount of ascites. Early onset of ovarian hyperstimulation syn-
drome was suspected. Conservative management was taken. Her
symptoms improved on the next day, and the patient was dis-
charged again from the ED.
The patient visited our out-patient clinic 9 days after TVOR,
complaining of persisted intermittent abdominal pain. She also
asked for menstrual manipulation. Intramuscular injection with
50 mg progesterone was given in hopes of reducing the patient's
anxiety and discomfort. However, her symptoms persisted andFigure 1. Plain abdominal ﬁlms showreported again to our ED for the third time on the 11th day after
TVOR. Right lower quadrant pain with abdominal fullness aggra-
vated and no bowel movement for 4 days were complaints. Follow-
up lab work-ups revealed persisted hyponatremia (Na 127 mg/dL).
Plain abdominal ﬁlm (Figure 1) showed distended colon and fecal
impaction. Due to persisted abdominal pain, the patient was hos-
pitalized on the 13th day after TVOR.
After admission, gastroenterologists were consulted and they
suspected Ogilvie's syndrome. Supportive care was suggested. For
persistent hyponatremia, nephrologists suggested it might be
related to syndrome of inappropriate antidiuretic hormone. How-
ever, on the 2nd day of her admission, generalized toniceclonic
seizure occurred twice. Her seizures lasted for several minutes
which ceased spontaneously before any intervention. Neurologists
were consulted. Brain CT showed a hypodense lesion at the right
parieto-occipital lobe. Abdominal CT revealed bilateral ovarian cysts
and markedly dilated colon. Dilantin was given for 6 consecutive
days as suggested by the neurologist, but another seizure episode
occurred. Brain magnetic resonance imaging was performed
and revealed amorphous lesions with hyperintensity on T2
weighted ﬂuid-attenuated inversion recovery (T2 FLAIR) imaging
(Figure 2) and hypointensity on diffuse weighted imaging in the
bilateral parieto-occipital and right frontal lobes, suggesting poste-
rior reversible encephalopathy syndrome. Also, dark brown color
urine was found during hospitalization. Urinary tests showeded progressive distended colon.
Figure 2. Brain MRI revealed amorphous lesions with hyperintensity on T2 FLAIR images in bilateral parieto-occipital and right frontal lobes. MRI ¼ magnetic resonance imaging.
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phyrin, and coproporphyrins. The patient's serum examinations
further showed a decrease in PBG deaminase level conﬁrming the
diagnosis of AIP.
The patient was transferred to the Neurology department under
the diagnosis of AIP and hemin (Ever Pharma Jena Gmbh, Germany)
was administered. The abdominal pain improved, but her neuro-
logical symptoms progressed to quadriplegia. After 2 weeks of
treatment in the Neurology ward, the patient's condition improved
slowly. She was sent to the rehabilitation department, and the
neurological symptoms continued to improve after 6 months of
rehabilitation. She regainedmost of her muscle power andwas able
to walk independently for a short distance.
Discussion
Alterationof theactivities of enzymes in thebiosyntheticpathway
of heme can cause metabolic disorders known as porphyrias.
According to the primary clinical presentations, porphyrias are
classiﬁedas acuteor cutaneous.AIP is themost common typeof acute
porphyria worldwide, with an estimated prevalence of approxi-
mately ﬁve per 1,000,000 [1]. Common neurovisceralmanifestations
for AIP include abdominal pain, gastrointestinal symptoms, muscle
weakness and psychiatric symptoms [2], but the symptoms could behighly variable. Abdominal pain is the most common and often the
earliest symptom of acute porphyria, affecting 85e95% of patients
with AIP. The pain is neuropathic, and therefore usually unremitted
and poorly localized [2]. Associated gastrointestinal symptoms
including constipation, bloating, nausea, vomiting, and signs of ileus
can be present at the same time. Inﬂammatory responses such as
abdominal tenderness, rebound tenderness, fever, and leukocytosis
are usually absent, but the presence of inﬂammatory signs cannot
exclude the attack of AIP. As the AIP has a nonspeciﬁc and variable
presentation, thediagnosis of AIP could easily bedelayed. Identiﬁable
exacerbating factors for AIP precipitating the onset of the disease are
discussed in the literature [2e5]. Progesterone has been proposed as
one of the exacerbating factors, supported by the evidence from
clinical observations [6,7]. In our case, a relatively high progesterone
level on the day of HCG administration, and an expected even
higher level of progesterone after TVORmay be important factors for
the exacerbation of the patient's AIP. Besides, the intramuscular
progestin administered on the patient's follow-up visit may also
contribute to the attack of AIP.
Ultrasound-guided TVOR was ﬁrst described in 1985 [8]. By
virtue of its simplicity, effectiveness and low rate of major com-
plications, it is now performed routinely worldwide for oocyte
pickup in IVF therapy. Nevertheless, despite its nature as a mini-
mally invasive procedure, the aspiration needle may inadvertently
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trauma on surrounding organs. Trauma on the bowel during the
TVOR remains a concern particularly when previous surgeries,
pelvic infection, or endometriosis has caused extensive adhesion
formation in the peritoneal cavity. However, in the literature,
damage to the bowel appears to be rare [9e11]. Only two cases of
perforated appendicitis following TVOR in which puncture holes
were found in the appendix have been published [9, 11]. Ludwig
et al [10] did a prospective study on > 1,000 oocyte retrievals and
found no case of bowel injury, and the author suggested that the
risk of damage to the bowel during an TVOR appears to be more
theoretical than actual with the direct visualization of the peri-
staltic bowel. However, the author also proposed that bowel in-
juries might actually occur more frequently and cause minor
symptoms without being diagnosed which resolve spontaneously
[10]. Abdominal pain after TVOR is a relatively common nonspeciﬁc
complaint. The symptoms of traumatized bowel include abdominal
pain, nausea, signs of ileus, and decrease bowel sounds couldmimic
the acute attack of AIP, making early diagnosis of AIP after TVOR
more difﬁcult. As the diagnosis of AIP requires speciﬁc tests which
are often not available in general medical facilities, it is time
consuming to establish a conﬁrmed diagnosis. High index of sus-
picion should therefore be taken if recurrent undiagnosed neuro-
visceral symptoms are found following IVF treatment.
Conclusion
Newly onset AIP during the course of IVF therapy is a rare but
possible complication. AIP should be taken into consideration for
those with persistent unexplained abdominal pain during
controlled ovarian hyperstimulation, especially when accompanied
with other neurological symptoms.Conﬂicts of interest
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